Phexxi

Product NDC: 69751-100
11-digit product format: 697510100
Labeler code: 69751
Product ID: 69751-100_11e3cfeb-3ae2-4e97-88f9-3e4cdf770659
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lactic acid, L-, citric acid monohydrate, and potassium bitartrate
Dosage form: GEL
Route: VAGINAL
Labeler: Evofem, Inc.
Application: NDA208352
Marketing category: NDA
Marketing start: 2020-08-01
Substance: CITRIC ACID MONOHYDRATE; LACTIC ACID, L-; POTASSIUM BITARTRATE
Active strength: 50; 90; 20 mg/5g; mg/5g; mg/5g
Pharmacologic classes: Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N208352-001	PHEXX	CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE	1%;1.8%;0.4%	GEL / VAGINAL		RLD, RS	2020-05-22

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N208352-001	10568855	2033-03-15	U-1		2020-06-03
N208352-001	11337989	2033-03-15	U-1		2022-09-06
N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15
N208352-001	11992472	2033-03-15	U-1		2024-06-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N208352-001	PHEXX	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`c0c555d07b60…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N208352-001	PHEXXI	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N208352-001	PHEXX	1%;1.8%;0.4%	GEL / VAGINAL	RLD, RS	2020-05-22	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 4 · 136 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208352-001	6706276	2024-03-06		Drug product	2020-06-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208352-001	6706276	2024-03-06		Drug product	2020-06-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208352-001	6706276	2024-03-06		Drug product	2020-06-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208352-001	10568855	2033-03-15	U-1		2020-06-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208352-001	11337989	2033-03-15	U-1		2022-09-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208352-001	11439610	2033-03-15		Drug substance, Drug product	2022-09-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208352-001	11992472	2033-03-15	U-1		2024-06-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208352-001	6706276	2024-03-06		Drug product	2020-06-03	`d8e5a09893c0…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208352-001	NP	2023-05-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N208352-001	NP	2023-05-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N208352-001	NP	2023-05-22	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N208352-001	NP	2023-05-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N208352-001	NP	2023-05-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N208352-001	NP	2023-05-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N208352-001	NP	2023-05-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N208352-001	NP	2023-05-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N208352-001	NP	2023-05-22	`c0c555d07b60…`
2023-12-20 04:57 UTC	2023-12	N208352-001	NP	2023-05-22	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N208352-001	NP	2023-05-22	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N208352-001	NP	2023-05-22	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N208352-001	NP	2023-05-22	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N208352-001	NP	2023-05-22	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N208352-001	NP	2023-05-22	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N208352-001	NP	2023-05-22	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208352-001	NP	2023-05-22	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N208352-001	NP	2023-05-22	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N208352-001	NP	2023-05-22	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N208352-001	NP	2023-05-22	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Phexxi
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LACTIC ACID, L-	90 mg/5g
CITRIC ACID MONOHYDRATE	50 mg/5g
POTASSIUM BITARTRATE	20 mg/5g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F9S9FFU82N	Internal UNII lookup
2968PHW8QP	Internal UNII lookup
NPT6P8P3UU	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2385348	Internal RxNorm lookup
2385353	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
173ff411-7227-47b0-94dc-844e1ebaf14e	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
69751-100-01	Phexxi	5 g in 1 APPLICATOR	GEL	5	7
69751-100-03	Phexxi	3 in 1 BOX	GEL	3	7
69751-100-12	Phexxi	12 in 1 BOX	GEL	12	7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
69751-100-12	GM - Gram	69751-100	ae3c1104-bead-40ba-bb35-6563b2e941a6	1	2020-08-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69751-100	PHEXXI (LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE) GEL [EVOFEM, INC.]	7	Current NDC, Legacy NDC, 3 package rows	20231122_173ff411-7227-47b0-94dc-844e1ebaf14e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Phexx	LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE	Evofem, Inc.	14b01a15-9b47-4be3-bb2e-a2010eab429e	2025-05-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 208352 application number: NDA208352
Phexxi	LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE	Evofem, Inc.	173ff411-7227-47b0-94dc-844e1ebaf14e	2023-11-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 208352 application number: NDA208352 ndc (product): 69751-100

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2968PHW8QP	CITRIC ACID MONOHYDRATE	5949-29-1	CITRIC ACID MONOHYDRATE
F9S9FFU82N	LACTIC ACID, L-	79-33-4	LACTIC ACID, L-
NPT6P8P3UU	POTASSIUM BITARTRATE	868-14-4	POTASSIUM BITARTRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2385348	lactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % Vaginal Gel	PSN	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385353	PHEXXI 1.8 % / 1 % / 0.4 % Vaginal Gel	PSN	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385353	citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG Vaginal Gel [Phexxi]	SBD	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385348	citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG Vaginal Gel	SCD	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385348	citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / K+ bitartrate 0.004 MG/MG Vaginal Gel	SY	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385353	citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / K+ bitartrate 0.004 MG/MG Vaginal Gel [Phexxi]	SY	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385348	citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / Pot bitartrate 0.004 MG/MG Vaginal Gel	SY	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385353	citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / Pot bitartrate 0.004 MG/MG Vaginal Gel [Phexxi]	SY	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385348	lactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % Vaginal Gel	SY	173ff411-7227-47b0-94dc-844e1ebaf14e	7
2385353	Phexxi (lactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % ) Vaginal Gel	SY	173ff411-7227-47b0-94dc-844e1ebaf14e	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69751-100-01	69751010001	5 g in 1 APPLICATOR	5 g					Historical
69751-100-03	69751010003	3 APPLICATOR in 1 BOX (69751-100-03) / 5 g in 1 APPLICATOR (69751-100-01)	3 applicator	2021-05-24	0000-00-00	Yes	No	Current
69751-100-12	69751010012	12 APPLICATOR in 1 BOX (69751-100-12) / 5 g in 1 APPLICATOR (69751-100-01)	12 applicator	2020-09-01	0000-00-00	No	No	Current